Skip to main content
. 2021 Mar 3;10(3):533. doi: 10.3390/cells10030533

Figure 1.

Figure 1

An overview of various approaches used in myostatin inhibition. Various factors and approaches in myostatin inhibition as outlined in Section 2 and Section 5. Treatments applied in clinical trials have been colored yellow. The Smad2/3 intracellular signaling pathway downstream the ActRIIB leads to altered gene transcription of muscle regulatory factors.